Rescription

RESCRIPTIONManage supplier listing

A live, adjudication-derived pharmacy cash-price matrix, plus the decision log built on it. The Rexi claims-adjudication engine compares multiple candidate prices for every drug at over 64,000 pharmacies nationwide, drawing on guaranteed published NADAC pricing and pharmacy cash-pay pricing, and selects the lowest available price at the point of sale. The byproduct is therefore not a scraped price list but a transaction-grade price table: for each NDC and quantity, the cash and contracted prices actually available at each pharmacy, continuously refreshed by real adjudications rather than periodic crawls. Alongside it sits the adjudication decision log — which pharmacy won each claim, what the rejected alternatives cost, and the size of the spread captured — which is a realized price-arbitrage record no public source provides. Member-facing lookup across 60,000+ pharmacies through the myRescription app adds a demand-side layer of member price-shopping queries, and the Saver Program, which applies point-of-sale savings to the most expensive drugs via health-system partnerships, implies negotiated or alternative price models on specialty drugs held only by this vendor.